CRONOS GROUP INC.

CRON ·Healthcare, Drug Manufacturers - General, Ontario, Canada
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $146.6M $117.6M $87.2M $86.7M $64.6M $46.7M $23.8M $12.1M
Cost of Revenue
Gross Profit $62.8M $25.2M $11.9M $15.4M $-17.6M $-25.8M $-17.6M $6.2M
Gross Margin 42.8% 21.4% 13.7% 17.8% -27.3% -55.3% -74.1% 51.3%
Operating Expenses
Research & Development $4.4M $4.2M $5.8M $13.1M $21.8M $20.4M $12.2M $1.8M
SG&A Expense $42.0M $46.5M $49.5M $67.7M $90.9M $80.6M $81.5M $13.3M
Operating Income $-17.4M $-76.5M $-84.8M $-111.4M $-292.0M $-219.4M $-153.3M $-20.4M
Operating Margin -11.9% -65.1% -97.2% -128.4% -452.2% -469.6% -645.5% -168.7%
Interest Expense $13.0K $27.0K $186.0K $1.2M $139.0K
Pretax Income $-17.1M $36.6M $-73.7M $-121.0M $-128.5M $-73.3M $1.17B $-20.9M
Income Tax Expense $-14.2M $-3.4M $-3.2M $34.2M $-431.0K $1.3M $0 $0
Net Income $-9.4M $41.1M $-74.0M $-168.7M $-396.1M $-73.1M $1.17B $-21.6M
Net Margin -6.4% 34.9% -84.8% -194.5% -613.5% -156.5% 4,911.6% -178.5%
EPS (Basic) $-0.02 $0.11 $-0.19 $-0.45 $-1.07 $-0.21 $3.76 $-0.12
EPS (Diluted) $-0.02 $0.11 $-0.19 $-0.45 $-1.07 $-0.21 $3.33 $-0.12
Shares Outstanding (Basic) 383.5M 382.1M 381.0M 377.0M 370.4M 351.6M 310.1M 172.3M
Shares Outstanding (Diluted) 383.5M 385.6M 381.0M 377.0M 370.4M 351.6M 342.8M 172.3M
Dividends Per Share
← Newer Page 1 of 2 Older →